From: Impact of HIF prolyl hydroxylase inhibitors in heart failure patients with renal anemia
Responder | Non-Responder | OR (95% CI) | p-value | |
---|---|---|---|---|
Baseline | ||||
TSAT < 20 | 2 | 5 | 0.27 (0.04–1.73) | 0.21 |
Ferritin < 100 | 4 | 8 | 0.14 (0.02–0.93) | 0.04 |
1 month later | ||||
TSAT < 20 | 0 | 5 | 0.09 (0.01–0.91) | 0.03 |
Ferritin < 100 | 3 | 6 | 0.10 (0.01–1.29) | 0.08 |
3 months later | ||||
TSAT < 20 | 1 | 5 | 0.15 (0.02–1.53) | 0.17 |
Ferritin < 100 | 7 | 9 | 0.56 (0.12–2.53) | 0.70 |